Cargando…

Tumor-derived exosomal HMGB1 promotes esophageal squamous cell carcinoma progression through inducing PD1(+) TAM expansion

Macrophages constitute one of the most common components of immune cells, which penetrate tumors and they have a key role in tumor prognosis. Here, we identified an unrecognized macrophage subpopulation, which favors tumorigenesis. These macrophages express programmed cell death protein 1 (PD1) in a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Bin, Song, Tie-Niu, Wang, Fu-Rong, Yin, Ci, Li, Zheng, Lin, Jun-Ping, Meng, Yu-Qi, Feng, Hai-Ming, Jing, Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6386749/ https://www.ncbi.nlm.nih.gov/pubmed/30796203 http://dx.doi.org/10.1038/s41389-019-0126-2

Ejemplares similares

PD‐L1/p‐STAT3 promotes the progression of NSCLC cells by regulating TAM polarization
por: Zhang, Rui, et al.
Publicado: (2022)

M1-like TAMs are required for the efficacy of PD-L1/PD-1 blockades in gastric cancer
por: Zhao, Rui, et al.
Publicado: (2020)

Exosomal HMGB1 Promoted Cancer Malignancy
por: Wang, Jiaan-Der, et al.
Publicado: (2021)

PTMA binds to HMGB1 to regulate mitochondrial oxidative phosphorylation and thus affect the malignant progression of esophageal squamous cell carcinoma
por: Chen, Shaogeng, et al.
Publicado: (2023)

Circulating exosomes from esophageal squamous cell carcinoma mediate the generation of B10 and PD‐1(high) Breg cells
por: Mao, Yu, et al.
Publicado: (2019)

M(2)-TAM subsets altered by lactic acid promote T-cell apoptosis through the PD-L1/PD-1 pathway
por: Shan, Tao, et al.
Publicado: (2020)

IL-2 Modulates TAMs Derived Exosomal MiRNAs to Ameliorate Hepatocellular Carcinoma Development and Progression
por: Chen, Hao, et al.
Publicado: (2022)

Wnt signaling induces radioresistance through upregulating HMGB1 in esophageal squamous cell carcinoma
por: Zhao, Yuanyuan, et al.
Publicado: (2018)

Tumor-derived exosomal HMGB1 fosters hepatocellular carcinoma immune evasion by promoting TIM-1(+) regulatory B cell expansion
por: Ye, Linsen, et al.
Publicado: (2018)

Peritumoral B cells drive proangiogenic responses in HMGB1-enriched esophageal squamous cell carcinoma
por: Kam, Ngar Woon, et al.
Publicado: (2021)

Exosome-based nanoimmunotherapy targeting TAMs, a promising strategy for glioma
por: Luo, Hong, et al.
Publicado: (2023)

PD-L1 mediates triple-negative breast cancer evolution via the regulation of TAM/M2 polarization
por: Meng, Ziqi, et al.
Publicado: (2022)

Biological Characteristics and Clinical Significance of Soluble PD-1/PD-L1 and Exosomal PD-L1 in Cancer
por: Niu, Mengke, et al.
Publicado: (2022)

The role of exosomal PD-L1 in tumor progression and immunotherapy
por: Xie, Feiting, et al.
Publicado: (2019)

The success of anti-PD-1 with chemotherapy for esophageal squamous cell carcinoma
por: van Laarhoven, Hanneke W.M., et al.
Publicado: (2023)

Tumor-associated macrophage (TAM)-derived CCL22 induces FAK addiction in esophageal squamous cell carcinoma (ESCC)
por: Chen, Jie, et al.
Publicado: (2022)

Cancer associated fibroblasts sculpt tumour microenvironment by recruiting monocytes and inducing immunosuppressive PD-1(+) TAMs
por: Gok Yavuz, Betul, et al.
Publicado: (2019)

Epigenetic Regulator KDM4D Restricts Tumorigenesis via Modulating SYVN1/HMGB1 Ubiquitination Axis in Esophageal Squamous Cell Carcinoma
por: Yao, Wenjian, et al.
Publicado: (2021)

HMGB1, anti-HMGB1 antibodies, and ratio of HMGB1/anti-HMGB1 antibodies as diagnosis indicator in fever of unknown origin
por: Chen, Mingkun, et al.
Publicado: (2021)

HMGB1 knockdown increases the radiosensitivity of esophageal squamous cell carcinoma by regulating the expression of molecules involved in DNA repair
por: Han, Guohu, et al.
Publicado: (2021)

HMGB1 induces radioresistance through PI3K/AKT/ATM pathway in esophageal squamous cell carcinoma
por: Zhang, Xueyuan, et al.
Publicado: (2022)

Lactate promotes macrophage HMGB1 lactylation, acetylation, and exosomal release in polymicrobial sepsis
por: Yang, Kun, et al.
Publicado: (2021)

Circular RNA circLPAR3 Facilitates Esophageal Squamous Cell Carcinoma Progression Through Upregulating HMGB1 via Sponging miR-375/miR-433
por: Cheng, Hongzhong, et al.
Publicado: (2020)

Prognostic value of PD-L1 in esophageal squamous cell carcinoma: a meta-analysis
por: Guo, Wei, et al.
Publicado: (2017)

The Role of TAMs in Tumor Microenvironment and New Research Progress
por: Feng, Yawei, et al.
Publicado: (2022)

ESRRG-PKM2 axis reprograms metabolism to suppress esophageal squamous carcinoma progression and enhance anti-PD-1 therapy efficacy
por: Wang, Tianxiao, et al.
Publicado: (2023)

Role of Integrin β1 in the progression and chemo-resistance of esophageal squamous cell carcinoma
por: Xie, Ying-Hua, et al.
Publicado: (2022)

Molecular profiles of different PD-L1 expression in patients with esophageal squamous cell carcinoma
por: Zhao, Songchen, et al.
Publicado: (2023)

Co-expression of High-mobility group box 1 protein (HMGB1) and receptor for advanced glycation end products (RAGE) in the prognosis of esophageal squamous cell carcinoma
por: Li, Lingzhao, et al.
Publicado: (2022)

Independent prognostic role of PD-L1 expression in patients with esophageal squamous cell carcinoma
por: Jiang, Dongxian, et al.
Publicado: (2016)

An RNA–RNA crosstalk network involving HMGB1 and RICTOR facilitates hepatocellular carcinoma tumorigenesis by promoting glutamine metabolism and impedes immunotherapy by PD-L1+ exosomes activity
por: Wei, Yanping, et al.
Publicado: (2021)

372 HMGB1 Localization as a Driver of Carcinogenesis in RDEB-Associated Squamous Cell Carcinoma
por: Bui, Kacey Guenther, et al.
Publicado: (2023)

Study of PD-1 Inhibitors in Combination with Chemoradiotherapy/Chemotherapy in Patients with Esophageal Squamous Carcinoma
por: Wei, Tianhui, et al.
Publicado: (2022)

Efficacy and safety of anti-PD-1 antibody plus chemoradiotherapy in locally advanced esophageal squamous cancer
por: Ma, Ji, et al.
Publicado: (2023)

TAM-ing T cells in the tumor microenvironment: implications for TAM receptor targeting
por: Peeters, Marlies J. W., et al.
Publicado: (2019)

Arsenic trioxide (ATO) induced degradation of Cyclin D1 sensitized PD-1/PD-L1 checkpoint inhibitor in oral and esophageal squamous cell carcinoma
por: Zhu, Guanxia, et al.
Publicado: (2020)

The link between intracellular calcium signaling and exosomal PD-L1 in cancer progression and immunotherapy
por: Alam, Md Rakibul, et al.
Publicado: (2023)

Role of Brg1 in progression of esophageal squamous cell carcinoma
por: Torkamandi, Shahram, et al.
Publicado: (2014)

Targeted Knockdown of IQGAP1 Inhibits the Progression of Esophageal Squamous Cell Carcinoma In Vitro and In Vivo
por: Wang, Xiao-Xia, et al.
Publicado: (2014)

The progression of HMGB1-induced autophagy in cancer biology
por: Xu, Tianwei, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_muca6i4cj7b3f3n0uacib430m4